11/07/2008 (Agence Europe) - The European Investment Bank (EIB) has granted B. Braun Melsungen AG (BBM) a loan of up to €125 million to expand its research infrastructure and develop innovative pharmaceutical products and production processes over the period 2008-2010. Facilities including a central laboratory and pharmaceutical clean rooms will be built at the firm's headquarters in Melsungen (Hessen). The EIB says that this investment will further strengthen BBM's position in the infusion therapy segment and upgrade the company's main production site. (O.L./transl.rt)